Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: A potent anti-craving effect?

Journal of Psychopharmacology

Volumn 19, Issue 3, 2005, Pages 301-305

  Kalyoncu, Ayhan ^a,b   Mirsal, H ^a   Pektas O ^a   Unsalan N ^a   Tan, D ^a   Beyazyurek M ^a  

^a MALTEPE UNIVERSITY   (Turkey)

^b Balikli Rum Hastanesi Vakfi   (Turkey)

Author keywords

Alcohol dependence; Clozapine; Craving; Lamotrigine; Schizophrenia

Indexed keywords

CLOZAPINE; LAMOTRIGINE;

ADULT; ALCOHOLISM; ANTICRAVING EFFECT; CASE REPORT; COMBINATION CHEMOTHERAPY; COMORBIDITY; DRUG EFFECT; HUMAN; MALE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

ADULT; ALCOHOLISM; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIAGNOSIS, DUAL (PSYCHIATRY); DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; MALE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TRIAZINES;

EID: 18844363205     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881105051542     Document Type: Review

References (24)

1. Albanese M J, Khantzian E J, Murphy S L, Green A I (1994) Decreased substance use in chronically psychotic patients treated with clozapine. Am J Psychiatry 151: 780-781
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. The American Psychiatric Association, Washington, DC
3. Buckley R, Thompson P, Way L, Meltzer H Y (1994) Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. Am J Psychiatry 757: 385-389
4. Chouljian T L, Shumway M I, Balancio E, Dwyer E V, Surber R, Jacobs M (1995) Substance use among schizophrenic outpatients: prevalence, course, and relation to functional status. Annal Clin Psychiatry 7: 19-24
5. Conley R R, Buchanan R W (1997) Evaluation of treatment-resistant schizophrenia. Schizophr Bull 23: 663-674
6. Cournos F, Empfield M, Horwath E, McKinnon K, Meyer L, Schrage H, Currie C, Agosin B (1991) HIV seroprevalence among patients admitted to two psychiatric hospitals. Am J Psychiatry 148: 1225-1230
7. Cuffel B J, Shumway M, Chouljian T L, MacDonald T (1994) A longitudinal study of substance abuse and community violence in schizophrenia. J Nerv Ment Dis 182: 704-708
8. Dursun S M, McIntosh D, Milliken H (1999) Clozapine plus lamotrigine in treatment-resistant schizophrenia. Arch Gen Psychiatry 56: 950
9. Dursun S M. Deakin J F (2001) Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study. J Psychopharmacol 15: 297-301
10. Drake R E, Osher F C, Wallach M A (1989) Alcohol use and abuse in schizophrenia. A prospective community study. J Nerv Ment Dis 177: 408-414
11. Drake R E, Antosca L M, Noordsy D L, Bartels S J, Osher F C (1991) New Hampshire's specialized services for the dually diagnosed. New Dir Ment Health Serv 50: 57-67.
12. Drake R E, Xie H, McHugo G J, Green A I (2000) The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull 26: 441-449
13. Elwers R D, Binnie C D (1996) Clinical pharmacokinetics of newer antiepileptic drugs: lamotrigine, vigabatrin, gabapentin, and oxcarbazepine. Clin Pharmacokinet 30: 403-415
14. Kalyoncu A, Mirsal H, Pektaş Ö, Şatir T, Serez M, Beyazyürek M (2000) A new treatment model for inpatient alcoholics. Journal of Dependence (Turkish) 1: 27-31
15. Kossen M, Selten J P, Kahn R S (2001) Elevated clozapine plasma level with lamotrigine. Am J Psychiatry 158: 1930
16. Litten R Z, Allen J, Fertig J (1996) Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991. Alcohol Clin Exp Res 20: 859-876
17. Richelson E (1996) Preclinical pharmacology of neuroleptics: Focus on new generation compounds. J Clin Psychiatry 57 (Suppl 11): 4-11
18. Regier D A, Farmer M E, Rae D S, Locke B Z, Keith S J, Judd L, Goodwin R (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264: 2511-2518
19. Saba G, Dumortier G, Kalalou K, Benadhira R, Degrassat K, Glikman J, Januel D (2002) Lamotrigine-clozapine combination in refractory schizophrenia: three cases. J Neuropsychiatry Clin Neurosci 14: 86
20. Swofford C D, Kasckow J W, Scheller-Gilkey G, Inderbitzin L B (1996) Substance abuse: a powerful predictor of relapse in schizophrenia. Schizophr Res 20: 145-151
21. Tiihonen J, Hallikainen T, Ryynanen OP, Repo-Tiihonen E, Kotilainen I, Kronen M, Toivonen P, Wahlbeck K, Putkonen A (2003) Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial. Biol Psychiatry 54: 1241-8
22. Wagstaff J, Bryson H M (1990) Clozapine. Drugs 40: 722-747
23. Xie X, Hagan R M (1998) Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder. Neuropsychobiology 38: 119-30
24. Zimmet S V, Strous R D, Burgess E S, Kohnstamm S, Green A I (2000) Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. J Clin Psychopharmacol 20: 94-98